Skip to Main Content

Author Details

Marlene H Frost
Mayo Clinic
1992
115
41
PMIDPaper TitleJournal TitlePublished Year
35088616Effects of patient-reported outcome assessment order.Clin Trials2022
36114500Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics.BMC Med Genomics2022
35046392Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning.NPJ Breast Cancer2022
34261476Somatic mutations in benign breast disease tissues and association with breast cancer risk.BMC Med Genomics2021
32718942Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy.Cancer Prev Res (Phila)2020
31933142Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.Breast Cancer Res Treat2020
33115421Deriving and validating a brief measure of treatment burden to assess person-centered healthcare quality in primary care: a multi-method study.BMC Fam Pract2020
30996252Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.Mod Pathol2019
31477010Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.BMC Genomics2019
29090365CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.Breast Cancer Res Treat2018
30029048Cellular fibroepithelial lesions of the breast: A long term follow up study.Ann Diagn Pathol2018
29932456Evaluation of 2 breast cancer risk models in a benign breast disease cohort.Cancer2018
29676945Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.J Clin Oncol2018
29167285Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.Cancer Prev Res (Phila)2018
28798985NanoString-based breast cancer risk prediction for women with sclerosing adenosis.Breast Cancer Res Treat2017
28337664Aromatase expression in atypical ductal hyperplasia in women.Breast Cancer Res Treat2017
28126725Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.Clin Cancer Res2017
28376198Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.J Natl Cancer Inst2017
28143431Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.BMC Cancer2017
29258587Association between mammographic breast density and histologic features of benign breast disease.Breast Cancer Res2017
28752190Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.Breast Cancer Res Treat2017
26846985Natural history of age-related lobular involution and impact on breast cancer risk.Breast Cancer Res Treat2016
26512815Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.Cancer2016
27352219Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.Cancer2016
27352099Breast cancer risk by the extent and type of atypical hyperplasia.Cancer2016
27488681Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.Breast Cancer Res Treat2016
26826407Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases.Hum Pathol2016
25192678Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.Ann Surg Oncol2015
26463853Improving Spiritual Well-Being in Patients with Lung Cancers.J Pastoral Care Counsel2015
26276747ERβ expression and breast cancer risk prediction for women with atypias.Cancer Prev Res (Phila)2015
26264469Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.Breast Cancer Res Treat2015
26210521Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.Breast Cancer Res Treat2015
26098779Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.Oncotarget2015
26202055Gene signature model for breast cancer risk prediction for women with sclerosing adenosis.Breast Cancer Res Treat2015
25863475Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort.Breast Cancer Res Treat2015
25624442Model for individualized prediction of breast cancer risk after a benign breast biopsy.J Clin Oncol2015
25639678Flat epithelial atypia and risk of breast cancer: A Mayo cohort study.Cancer2015
23434836Caregivers of patients with cancer fatigue: a high level of symptom burden.Am J Hosp Palliat Care2014
25200244Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.Breast J2014
24510013Sclerosing adenosis and risk of breast cancer.Breast Cancer Res Treat2014
24596048Immune cell quantitation in normal breast tissue lobules with and without lobulitis.Breast Cancer Res Treat2014
24480577Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Cancer Prev Res (Phila)2014
24019196Spiritual quality of life in advanced cancer patients receiving radiation therapy.Psychooncology2014
22930253Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer.Cancer2013
24265598A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care.PLoS Med2013
23420557Spiritual well-being in lung cancer survivors.Support Care Cancer2013
21881938Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.Breast Cancer Res Treat2012
23087047Benign breast disease and the risk of subsequent breast cancer in African American women.Cancer Prev Res (Phila)2012
22288965Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.Arch Pathol Lab Med2012
22169704Spiritual well-being and quality of life of women with ovarian cancer and their spouses.J Support Oncol2012
  • 1 - 50 of 115

Recommended Authors

Jennifer Y Y Kwan
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2013
Number of shared co-authors 0
Shayna L Showalter
University of Virginia School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Roxanne E Jensen
National Cancer Institute
Career Start Year 2007
Number of shared co-authors 3
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Kathryn J Ruddy
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 22
Nora Horick
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
Fay J Hlubocky
Maclean Center for Clinical Medical Ethics, University of Chicago Medicine
Career Start Year 2003
Number of shared co-authors 0
Lorna Kwan
David Geffen School of Medicine, University of California los angeles
Career Start Year 2001
Number of shared co-authors 0
Ian K Komenaka
Ironwood Cancer and Research Centers, AZ Arizona Cancer Center, University of Arizona
Career Start Year 1999
Number of shared co-authors 3
Sandhya Pruthi
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 16
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 2
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Craig C Earle
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
Alexandra L Hanlon
Virginia Tech
Career Start Year 1994
Number of shared co-authors 0
Arash Naeim
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
Janet S Carpenter
From the Indiana University School of Nursing
Career Start Year 1994
Number of shared co-authors 1
Michael Brundage
Cancer Centre of Southeastern Ontario
Career Start Year 1993
Number of shared co-authors 3
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Jeffrey Peppercorn
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 0
Lee S Caplan
and Clinical Research Center, Morehouse School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Marilyn M Schapira
University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 0
Mary S Dietrich
Vanderbilt University School of Nursing
Career Start Year 1989
Number of shared co-authors 0
Madeline Li
University of Toronto
Career Start Year 1989
Number of shared co-authors 0
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Karen L Weihs
University of Arizona Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Gary Rodin
Princess Margaret Cancer Centre (University Health Network)
Career Start Year 1980
Number of shared co-authors 0
John W Waterbor
University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 0
Patricia J Hollen
University of Virginia School of Nursing
Career Start Year 1978
Number of shared co-authors 0
Dietlind L Wahner-Roedler
Mayo Clinic
Career Start Year 1975
Number of shared co-authors 9
Nancy K Janz
School of Public Health, University of Michigan ann arbor
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Amy C Degnim
Mayo Clinic
Co-authored papers 52
Jeff A Sloan
Mayo Clinic
Co-authored papers 26
Stacey J Winham
Mayo Clinic
Co-authored papers 23
Tanya L Hoskin
Division of Biostatistics and Clinical Trials, Mayo Clinic
Co-authored papers 22
Judy C Boughey
Mayo Clinic
Co-authored papers 11
Mark E Sherman
Mayo Clinic
Co-authored papers 8
Paul J Novotny
Mayo Clinic
Co-authored papers 8
Kathleen R Brandt
Mayo Clinic
Co-authored papers 6
Christi A Patten
Mayo Clinic
Co-authored papers 5
Daniel J Schaid
Mayo Clinic
Co-authored papers 5
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 5
Shannon K McDonnell
Mayo Clinic
Co-authored papers 4
Vera J Suman
Mayo Clinic
Co-authored papers 4
Ping Yang
Mayo Clinic
Co-authored papers 3
David T Eton
Mayo Clinic
Co-authored papers 3
Clive S Grant
Inova Health System
Co-authored papers 3
Lee J Melton
Mayo Clinic
Co-authored papers 3
Kathleen J Yost
Mayo Clinic
Co-authored papers 2
Ron D Hays
Fielding School of Public Health, University of California at Los Angeles
Co-authored papers 2
Richard J Santen
Co-authored papers 2
Christopher G Scott
Mayo Clinic
Co-authored papers 2
Per Hall
Co-authored papers 2
Timothy J Beebe
University of Minnesota School of Public Health
Co-authored papers 2
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Andrea M Barsevick
Thomas Jefferson University
Co-authored papers 2
Dorret I Boomsma
Co-authored papers 1
Nancy L Pedersen
Co-authored papers 1
Piet C de Groen
University of Minnesota
Co-authored papers 1
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers 1
Ruth M Pfeiffer
National Cancer Institute.
Co-authored papers 1
Release 1.2